Tissue regeneration requires the selective activation and repression of specific signaling pathways in stem cells. As such, the Wnt signaling pathways have been shown to control stem cell fate. In many cell types, the R-Spondin (Rspo) family of secreted proteins acts as potent activators of the canonical Wnt/!-catenin pathway. Here, we identify Rspo1 as a mediator of skeletal muscle tissue repair. Firstly we show that Rspo1-null muscles do not display any abnormalities at the basal level. However deletion of Rspo1 results in global alteration of muscle regeneration kinetics following acute injury. We found that muscle stem cells lacking Rspo1 show delayed differentiation. Transcriptome analysis further demonstrated that Rspo1 is required for the activation of Wnt/!-catenin target genes in muscle cells. Furthermore, muscle cells lacking Rspo1 fuse with a higher frequency than normal cells, leading to larger myotubes containing more nuclei both in vitro and in vivo. We found the increase in muscle fusion was dependent on upregulation of non-canonical Wnt7a/Fzd7/Rac1 signaling. We conclude that antagonistic control of canonical and non-canonical Wnt signaling pathways by Rspo1 in muscle stem cell progeny is important for restitution of normal muscle architecture during skeletal muscle regeneration.
SUMMARY
Tissue regeneration requires the selective activation and repression of specific signaling pathways in stem cells. As such, the Wnt signaling pathways have been shown to control stem cell fate. In many cell types, the R-Spondin (Rspo) family of secreted proteins acts as potent activators of the canonical Wnt/!-catenin pathway. Here, we identify Rspo1 as a mediator of skeletal muscle tissue repair. Firstly we show that Rspo1-null muscles do not display any abnormalities at the basal level. However deletion of Rspo1 results in global alteration of muscle regeneration kinetics following acute injury. We found that muscle stem cells lacking Rspo1 show delayed differentiation. Transcriptome analysis further demonstrated that Rspo1 is required for the activation of Wnt/!-catenin target genes in muscle cells. Furthermore, muscle cells lacking Rspo1 fuse with a higher frequency than normal cells, leading to larger myotubes containing more nuclei both in vitro and in vivo. We found the increase in muscle fusion was dependent on upregulation of non-canonical Wnt7a/Fzd7/Rac1 signaling. We conclude that antagonistic control of canonical and non-canonical Wnt signaling pathways by Rspo1 in muscle stem cell progeny is important for restitution of normal muscle architecture during skeletal muscle regeneration.
INTRODUCTION
Adult muscle stem cells, called satellite cells (MuSCs), located around the differentiated myofibers exist in a quiescent state and are readily identified through their expression of the Paired-Box transcription factor Pax7 (Seale et al., 2000) . Following injury to the host myofibers they become activated and proliferate give rise to muscle progenitor cells expressing the myogenic regulatory factors MyoD and Myogenin which act to promote differentiation (Chargé and Rudnicki, 2004) . Differentiating myocytes will then fuse together to form myotubes that will further mature into new myofibers. Myocyte differentiation and fusion processes are highly regulated (Abmayr and Pavlath, 2012) . Perturbations in migration, adhesion or membrane fusion can give rise to defects in the reconstitution of muscle architecture. As such, accelerated fusion can lead to the formation of giant dystrophic myofibers (Charrin et al., 2013) while a reduction in myocyte fusion potential results in smaller muscles with myofibers containing fewer nuclei (Horsley et al., 2003) . This is exemplified in skeletal muscle pathologies such as Duchenne Muscle Dystrophy (DMD). In dystrophic muscles, the continuous regeneration process led to the formation of abnormal fibers, termed branched or split fibers, which are more prone to damage during contraction (Chan et al., 2007) , lack force generation, and contribute to the disease progression (Head, 2010) .
The WNT signaling pathways are crucial regulators of adult muscle regeneration (von Maltzahn et al., 2012) . The canonical Wnt/!-catenin pathway is required for muscle progenitor cell differentiation and regulate both skeletal muscle development (Borello et al., 2006 , Anakwe et al., 2003 and repair following injury (Brack et al., 2009 , Parisi et al., 2015 . In contrast, the noncanonical Wnt7a/Fzd7 signaling pathway stimulates skeletal muscle growth and repair by inducing the symmetric expansion of satellite stem cells through the planar cell polarity (PCP) pathway (Le Grand et al., 2009 ) and by activating the anabolic Akt growth pathway in myofibers (von Maltzahn et al., 2012) . Recently it was shown that Wnt7a/Fzd7/Rac1 signaling enhance MuSCs and myoblasts migration (Bentzinger et al., 2014) . In many tissues, both canonical (Carmon et al., 2011) and non-canonical (Glinka et al., 2011 ) Wnt pathways can be overstimulated by R-spondins. The R-spondin family is comprised of four different secreted proteins (RSPO1-4) (de Lau et al., 2012) . Each R-spondin has its own expression pattern and properties.
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4 R-spondins interact with leucine-rich repeat-containing G protein-coupled receptors (LGR) (de Lau et al., 2011) .
LGRs allow a potentiation of the Wnt signaling pathways in response to Rspondins by neutralizing the E3 ligases RNF43 and ZNRF3 which act to remove Wnt receptors from the stem cell surface (Koo et al., 2012 , Hao et al., 2012 .
Number of studies reported the essential roles played by R-spondins both during embryonic development, adult tissue homeostasis and repair. Thus, Rspo1 is required for female sexual development and Rspo1-null mice show masculinized gonads (Parma et al., 2006 , Chassot et al., 2008 . In adult tissues, RSPO1 promotes growth of the intestinal epithelium (Kim et al., 2005) and is a beta-cell growth factor in the pancreas (Wong et al., 2010) . Moreover, Lgr5/Rspo1-expressing stem cells are able to regenerate hepatocytes and bile ducts upon liver damage in vivo (Huch et al., 2013) . To date, the role of R-spondins in regenerative myogenesis remains unclear.
It is known that R-spondins are also expressed in muscle cells and the C2C12 myoblast cell line has been shown to express Rspo2 and Rspo3. In these cells, RSPO2/LGR4 regulate myogenic differentiation (Han et al., 2011) . A recent report documented that Rspo1 transcript expression was strongly up-regulated in primary myoblasts over-expressing PAX7 compared to control cells (Soleimani et al., 2012) . However, so far the role of R-spondins in regenerative myogenesis remains undetermined. Here we aimed to investigate the function of Rspo1 in steady-state muscle as well as during regeneration.
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RESULTS
Muscle satellite cells express the Pax7 target gene Rspo1.
To further validate the expression of Rspo1 in adult MuSCs, we performed immunocytochemical analysis for PAX7 and RSPO1 on myofibers isolated from Extensor Digitorum Longus (EDL) muscles. We observed that quiescent MuSCs expressed RSPO1 proteins and that activated MuSCs on cultured myofibers (24 hours after isolation) expressed relatively higher levels of RSPO1 proteins ( Figure 1A ). Of note, RSPO1 is mostly cytoplasmic in quiescent MuSCs and appears both cytoplasmic and nuclear in activated MuSCs. Analysis of primary myoblasts cultured in vitro further confirmed the expression of RSPO1 by differentiating muscle progenitor cells ( Figure 1B ).
Since Rspo1 expression was shown to be strongly up-regulated in myoblasts expressing Pax7-Flag, we tested if Rspo1 is a direct target of Pax7 in adult myogenic cells. To this aim, we asked whether PAX7 proteins can bind to a putative binding site localized 35kb upstream of Rspo1 gene identified by Chromatin Immunoprecipitation (ChIP) coupled with deep sequencing (Soleimani et al., 2012) . ChIP assays were thus performed using primary myogenic cell cultures expressing Pax7-Flag. They demonstrated that PAX7 proteins were bound close to the Rspo1 gene as well as to the positive controls (Myf5 -111kb and -57kb enhancer regions), as relative to a mock IP and to the negative controls (IgH and Gapdh loci) ( Figure 1C ). These results indicate that Rspo1 is a direct target of PAX7 in adult muscle progenitor cells.
Rspo1 is not required for muscle tissue formation
We therefore investigated whether Rspo1 plays a role in the adult skeletal muscle tissue. To this aim, we bred constitutive Rspo1 knock-out mice (Chassot et al., 2008) . Homozygous mutant mice present a complete Rspo1 loss-of-function leading to female-to-male sex reversal and sterility in females, otherwise heterozygous mice are phenotypically normal and fertile. We did not observe any phenotypic difference in skeletal muscle histology of young adult (8 weeks-old) Rspo1-null compared to control mice (controls are wild-type and Rspo1-heterozygous mice) as shown by hematoxylin and eosin staining of Tibialis Anterior (TA) muscles ( Figure S1A ) and by measuring the weights of multiple limb muscles ( Figure S1B ). In TA muscles, loss of Rspo1 expression did not influence the numbers of myofibers ( Figure S1C ), their size ( Figure S1D ) and the crosssectional area (CSA) distribution ( Figure S1E ). In agreement with these findings, quantification of the number of myonuclei per myofiber ( Figure S1F ) and of the entire muscle CSA ( Figure   S1G ) did not show any significant difference between the two genotypes. Furthermore, Rspo1-null and control animals showed similar number of Pax7-expressing MuSCs on TA ( Figure S1H) Soleus, Gastrocnemius and Triceps (data not shown) cryosections. Our analysis suggests that Rspo1 is not required for myofiber formation and cellular organization or for the establishment of the MuSC population.
Rspo1 regulates skeletal muscle tissue regeneration
To address whether Rspo1 is involved in skeletal muscle regeneration, we injured TA muscles from control and Rspo1-null mice by cardiotoxin injection (Vignaud et al., 2007) . During the early phase of tissue regeneration (4d.p.i.) (Figure 2A ), the number of Pax7+ progenitors was similar between control and Rspo1-null muscles ( Figure 2B ), but Rspo1-null muscles contained decreased numbers of Myogenin+ differentiating cells ( Figure 2C ) and of nuclei incorporated in myotubes compared to control muscles ( Figure 2D ), suggesting a delay in the differentiation process in Rspo1-null tissue. Later, at 7 d.p.i, (Figure 2E ), newly formed myofibers were of similar caliber between both genotypes ( Figure 2F ) and the numbers of Myogenin+ cells inside myofibers was increased in Rspo1-null muscles compared to control muscles ( Figure 2G ), suggesting a compensatory enhancement of fusion in Rspo1-null muscles. At this time point, the number of Pax7+ progenitors remained similar between Rspo1-null and control muscles ( Figure   2H ).
To further evaluate the effect of Rspo1 mutation on muscle repair, we analyzed the morphology and cellular composition of regenerated muscles, 62 days after injury ( Figure 2I ). Strikingly, regenerated Rspo1-null muscles were larger (Figures 3J) and heavier ( Figure 3K ) compared to control muscles. Regenerated Rspo1-null muscles were composed of larger myofibers ( Figure 3L and Figure 3M ) containing a higher number of myonuclei ( Figure 3N and Figure 3O 
Rspo1 does not influence primary myoblasts proliferation
To further analyze the behavior of muscle cells devoid of Rspo1, we cultured primary myoblasts expanded from MACS-sorted MuSCs. We observed that Rspo1-null cells do not show an aberrant morphology and expressed the muscle progenitor marker M-cadherin ( Figure S2A ) (Cornelison and Wold, 1997) . While proliferating, control and Rspo1-null myoblasts expressed similar levels of Pax7 transcript expression ( Figure S2C ) and more than 98% of the cells expressed PAX7 protein ( Figure S2B ). Immunostainings for the mitosis marker phosphoHistoneH3 ( Figure 4D ) and the cell cycle marker MKI67 ( Figure S2E ) did not reveal any differences in the number of cycling cells between Rspo1-null and control cells. Likewise, quantification of the proportion of cells engaged in S phase by EdU incorporation assay ( Figure   S2F ) did not show any difference between control and Rspo1-null cells in either high serum ( Figure S2G ) or low serum ( Figure S2H ) culture conditions. Our results demonstrate that Rspo1 is not required for myogenic progenitor expansion from MuSCs.
Rspo1 positively controls muscle cell differentiation through the Wnt/!-catenin pathway
We further induced Rspo1-null and control primary myoblasts to differentiate in vitro and quantified the number of myocytes expressing Myogenin at different time points following serum removal ( Figure 5A ). Similar to our in vivo observations, Rspo1-null myocytes showed a significant differentiation delay compared to control myocytes, and this delay was compensated after 2 days in differentiation medium ( Figure 5B ). To understand the molecular mechanisms regulated by Rspo1 in muscle cells, we performed Affymetrix microarrays on Rspo1-null and control myocytes. Analysis of the transcriptome data identified the down-regulation of a large number of genes implicated in skeletal myogenesis in Rspo1-null cells compared to control cells ( Figure 5C ). By analyzing our microarray data with the Upstream Regulators tool of the Ingenuity Pathway Analysis (IPA) software, we identified the myogenic determination factor MYOD1, as the most inhibited regulator in Rspo1-null cells ( Figure 5D ). We then validated the down-regulation of MyoD transcripts by qRT-PCR ( Figure 5E ) thus explaining the delay in differentiation of Rspo1-null muscle progenitor cells observed in vitro and in vivo.
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The IPA tool further highlighted a down-regulation in the expression of a set of genes implicated in canonical Wnt pathway in Rspo1-null cells ( Figure 5F ). We validated that the expression levels of the !-catenin target genes Follistatin (Fst) ( Figure 5G ) and Bmp2 ( Figure 5H ) were decreased in Rspo1-null myocytes compared to control cells. We then investigated if Wnt/!-catenin target genes expressions could be induced in Rspo1-null cells following exogenous ligand stimulation.
Following WNT3A protein treatment, control myocytes exhibited elevated expression of Fst ( Figure 5I ), Gja5 ( Figure 5K ) and Tgf!2 ( Figure 5M ), three genes that we previously showed to be responsive to !-catenin activation in muscle cells (Rudolf et al., 2016) . In contrast, Rspo1-null myocytes did not respond to exogenous WNT3A stimulation, as expression levels of Fst ( Figure   5J ), Gja5 ( Figure 5L ) and Tgf!2 ( Figure 5N ) remained similar in WNT3A-treated cells and in mock-treated cells. We then quantified the expression of active-!-catenin proteins in nuclear and cytoplasmic fractions by Western Blot ( Figure 5O ). We observed that while active-!-catenin proteins are elevated and translocated to the nuclei of control cells following Wnt ligand stimulation, they remain unchanged in Rspo1-null cells following WNT3A treatment ( Figure 5P ).
Since activation of Wnt/!-catenin signaling is required in muscle progenitor cells to properly differentiate (Rudolf et al., 2016) , we hypothesize that a lack of !-catenin activation in Rspo1-null myocytes could explain the observed delay in differentiation. To stabilize !-catenin proteins in muscle cells, independently of the extracellular ligands, we used the small molecule CHIR99021 to inhibit GSK3 and subsequently the !-catenin destruction complex. Quantification of the number of differentiated cells in control and in Rspo1-null myocytes, after treatment with either WNT3A or CHIR99021, showed that the forced-activation of the Wnt/!-catenin pathway in Rspo1-null cells restore a control state of differentiation. Taken together, our data suggest that Rspo1 expression is required for the activation of the canonical Wnt pathway during myogenic differentiation.
Rspo1 limits cell fusion
We next investigated muscle cell fusion in Rspo1-null and control primary myocytes. After four days in differentiating conditions, control myocytes fused and generated both thin and large myotubes, while Rspo1-null cells generated larger syncytia ( Figure 4A ). As such, the number of myotubes per surface was reduced in Rspo1-null cultures, compared to control cells ( Figure 4B) and the average diameter of Rspo1-null myotubes was higher compared to control myotubes (Figure 4 ). Graphical distribution of myotubes size further demonstrated that this increase was homogenous and not due to the appearance of a specific sub-population ( Figure 4D ). Importantly, while the percentage of nuclei that underwent fusion was similar in cultures of both genotypes ( Figure 4E ), we observed a significantly higher proportion of myotubes containing more than 7 nuclei in Rspo1-null cultures compared to the control cultures ( Figure 4F ). Our results indicate that Rspo1 negatively regulates muscle cell fusion and that its absence leads to the generation of larger myotubes containing more nuclei.
Rspo1 negatively regulates the non-canonical Wnt7a/Fzd7/Rac1 pathway
Our data suggests that Rspo1 has contradicting roles in muscle progenitor cell differentiation and fusion. We thus hypothesized that Rspo1 depletion could also impact the non-canonical Wnt pathway. It is known that WNT7A promotes the activation of the Wnt/PCP pathway in MuSCs (Le Grand et al., 2009 ). It was also recently shown that WNT7A stimulate the migration of MuSCs and primary myoblasts through RAC1 activation (Bentzinger et al., 2014) . We thus validated, that WNT7A stimulation of wild-type differentiating myocytes results in enhancement of muscle fusion, as shown by increased myotube size ( Figure S3A ) and higher numbers of myonuclei ( Figure S3B ) in WNT7A-stimulated myotubes compared to mock-treated cells. As such, up-regulation of non-canonical Wnt7a signaling could explain the increased fusion we observed in Rspo1-null muscle cells.
To test this hypothesis, we first quantified the migration of control and Rspo1-null myocytes in scratch-wound assays ( Figure 5A ). We observed that Rspo1 deficiency increased myocyte migration ( Figure 5B) . To test the effect of Rspo1 on MuSC migration, we then used time-lapse imaging on single myofibers (Otto et al., 2011) . In this condition, the mean velocity of Rspo1-null MuSCs was lower than the mean velocity of control cells ( Figure 5C ). Interestingly, timelapse imaging of myocytes migrating in wound assays revealed that Rspo1 deficiency significantly increased both the mean velocity ( Figure 5D ) and the minimum speed ( Figure 5E) when compared with controls. These results indicate that Rspo1 inhibits the motility of myogenic progenitor cells, but not MuSCs, during directed migration.
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The major receptor of WNT7A in myogenic cells is Frizzled-7 (Fzd7) (Le Grand et al., 2009 ) and it accumulates in the periphery of moving cells during migration (Bentzinger et al., 2014) . We thus performed immunolocalization of FZD7 in primary myocytes, and observed that while few cells show FZD7 accumulation in control and WNT3A-treated conditions, FZD7 staining appeared stronger and polarized in both WNT7A-treated cells and Rspo1-null cells ( Figure 5F ).
We also observed an increase in Fzd7 gene expression in Rspo1-null cells compared to control cells ( Figure 5G ). Both these results suggest an enhancement of non-canonical Wnt7a/Fzd7 signaling in Rspo1-null cells.
We next transfected both control and Rspo1-null cells with siRNA directed against Fzd7 in order to block the non-canonical WNT7A pathway ( Figure 5G ). We then quantified the number of migrating cells in scratch wound assays ( Figure 5H ) and observed that siFzd7 treatment decreased cell migration in both control and Rspo1-null cells. Importantly, Rspo1-null cells treated with siFzd7 migrated with a rate similar to control cells, indicating that the increase in cell motility observed in Rspo1-null cells is related to an increase in Wnt7a/Fzd7 signaling ( Figure 5I ).
To further investigate whether the improved muscle cell fusion resulting from Rspo1 deficiency is dependent on up-regulation of Wnt7a/Fzd7/Rac1 signaling, we differentiated control and Rspo1-null myocytes, in control and Fzd7 silencing conditions or in the presence of RAC1 inhibitor EHop-016 (Montalvo-Ortiz et al., 2012) ( Figure 5J ). Strikingly, treatment of Rspo1-null cells with either siFzd7 or EHop-16 restored the proportion of large myotubes containing more than 7 nuclei to a percentage similar to untreated control cells ( Figure 5K ). Interestingly, siFzd7 treatment resulted in a small reduction in fusion index in both controls and Rspo1-null cells ( Figure 5L ).
Taken together, our results indicate that Rspo1 negatively regulates muscle cell migration and fusion by dampening non-canonical Wnt7a/Fzd7/Rac1 pathway. Our data suggest that, in MuSCs progeny, Rspo1 acts as a regulator of both canonical and non-canonical Wnt signaling pathways, and that it integrates antagonistic pathways for fine-tuning of muscle architecture during tissue repair.
DISCUSSION
In most mammalian tissues, the R-spondin family of secreted proteins positively regulates the canonical Wnt signaling pathway (Carmon et al., 2011) by neutralizing Rnf43 and Znrf3, two transmembrane E3 ligases that remove Wnt receptors from the cell surface (de Lau et al., 2014) .
Canonical Wnt signaling plays an important role in adult muscle regeneration, through allowing for the timely differentiation of MuSC descendants during tissue repair (Figeac and Zammit, 2015, Rudolf et al., 2016 ). Here we show that the absence of Rspo1 expression significantly affects myogenic progenitor cells differentiation both in vitro and in vivo, and is associated with a defect in canonical Wnt/!-catenin activation. These results are consistent with previous reports demonstrating that RSPO1 is a regulator of tissue-resident stem cells such as the mammary gland (Cai et al., 2014) , the skin (Li et al., 2016) or the intestine (de Lau et al., 2011) . As such, Wnt7a overexpression enhance muscle regeneration and increase both satellite cell numbers and the proportion of satellite stem cells (Le Grand et al., 2009 , von Maltzahn et al., 2012 . In contrast, while we observed that Rspo1 deficiency resulted in over-activation of Wnt7a/Fzd7/Rac1 pathway in differentiating myocytes, we did not quantify any differences in the numbers of PAX7-expressing myogenic progenitors during muscle regeneration or in the MuSCs pool after regeneration is finished. Further to that point, while Rspo1-null myocytes are faster than control cells, Rspo1-null MuSC on single fiber are not. Our data suggests that RSPO1 does not influence the non-canonical Wnt pathway in MuSC. We hypothesize that this stage-specific requirement for RSPO1 action is related to the fact that canonical Wnt/!-catenin signaling is inactive in MuSC, but activated in differentiating myogenic progenitor cells (Rudolf et al., 2016) .
We propose that Rspo1 controls the antagonistic balance between canonical and non-canonical Wnt pathways specifically in differentiating muscle progenitor cells.
Both canonical and non-canonical Wnt signalings induce distinct cellular and molecular processes but share several core components. Thus, the exclusive activation of a Wnt pathway is possible by the selective interaction between specific ligands and receptors. More precisely, it has been shown that WNT5a can inhibit or activate !-catenin signaling depending on the presence of specific Frizzled receptors at the membrane (Mikels and Nusse, 2006) . It is also well documented that canonical and non-canonical Wnt ligands can compete for the activation of their selective pathways. In Xenopus embryos, ectopic non-canonical WNT5a can antagonize canonical WNT8 and !-catenin activation (Larabell et al., 1997) . In mammals, non-canonical WNT5a has been shown to inhibit WNT3a-mediated canonical Wnt signaling in hematopoietic stem cells (Nemeth et al., 2007) . The increase in non-canonical Wnt signaling observed in Rspo1-null muscle cells could then be related to a change in the composition of surface receptors. We propose that RSPO1 has a role in maintaining the "canonical" Frizzled receptors at the surface of muscle cells, and that its absence can lead to a preferential increase in the availability of non-canonical Our data show that Rspo1-null muscles can regenerate efficiently and show increase muscle progenitor cell fusion leading to larger syncytia containing more myonuclei compared to control muscles. As such, blocking RSPO1 function in vivo in myodegenerative diseases or in conditions of muscle atrophy due to ageing or cancer-driven cachexia may represent an interesting strategy for enhancing intrinsic muscle repair. In contrast, the regeneration of bigger myofibers can also be described as a pathological context since it can perturb muscle homeostasis and function. An example is the hyper-muscular Myostatin-null mice, in which lack of MYOSTATIN promotes growth of skeletal muscle, but compromises force production (Amthor et al., 2007) . Precisely, muscles from Myostatin-null mice, although larger and stronger, fatigue extremely rapidly (Mouisel et al., 2014) . As such, delivery of RSPO1 protein could serve as a therapeutic treatment in muscle pathologies that show aberrant or elevated muscle progenitor fusion such as Duchenne Muscle Dystrophy.
METHODS
Mice
Experimental animal protocols were performed in accordance with the guidelines of the French Veterinary Department and approved by the University Paris-Descartes Ethical Committee for Animal Experimentation. The R-spondin1 knock-out mice were a gift from M-C. Chaboissier (Institut de Biologie Valrose, Nice, France). All experiments were performed in 6-to 9-weeksold mice. Our animals are on C57B6N/SV129 genetic background. Mice genotyping has been described previously (Chassot et al., 2008) .
Cardiotoxin injury
Mice were anaesthetized by intraperitoneal injection of Ketamin at 0,1mg per gram body weight and Xylazin at 0,01mg per gram body weight diluted in saline solution. After having cleaned the mouse hind legs with alcohol, tibialis anterior muscles were injected with 50"l of cardiotoxin solution (Latoxan, 12 "M in saline) using an insulin needle.
Muscle histology and immunohistochemistry
For cryosections, TA were submerged in Tissue-Tek O.C.T. compound from Cell Path.
Beforehand, isopentane was cooled in liquid nitrogen. Muscles were then frozen on the cooled isopentane and cut in 10 "m section with a Leica cryostat. Frozen muscle were stored at -80°C.
Sections were fixed with 4% PFA in PBS during 20 min and permeabilized with cooled-methanol.
Antigen retrieval was performed with the Antigen Unmasking Solution (Vector) at 95°C for 10 min. Sections were then blocked with 4% BSA, 5% Goat serum in PBS during 3h and incubated with primary antibody overnight at 4°C. Alexa Fluor secondary antibody was incubated on sections 1h at room temperature and nuclei were stained with Hoechst. Slides were mounted in fluorescent mounting medium from Dako. Primary antibodies used were Laminin (Santa Cruz), Pax7 (Santa Cruz), Myogenin (Santa Cruz) and Dystrophin (Leica). For Hematoxilin/Eosin staining, sections were incubated in Hematoxilin bath for 4 min and with Eosin for 2 min and thereafter dehydrated in 70%, 90% and 100% ethanol and fixed in Xylene bath for 2 min.
Muscle stem cells isolation and primary myoblasts culture
Skeletal muscles of mice were dissected (Quadriceps, TA, EDL, Gastrocnemius, Soleus, Gluteus) and transferred to a sterile Petri dish on ice. Muscles were incubated in 1,5U/mL of CollagenaseB -2,4U/mL of DispaseII -2M of CaCl 2 solution for 45min at 37°C with periodic mechanical digestion. Fetal Bovine Serum was added to stop the digestion. After centrifugation, pellet was resuspended in growth medium consisting of Ham's F10 (Life Technologies) with 20% FBS (Eurobio), 1% Pen/Strep (Life Technologies), 2.5 ng/"l basicFGF (R&D Systems). Satellite cells were then purified using MACS cell separation system, according to the manufacturer's protocol.
Satellite cells are then let to proliferate and give rise to primary myoblasts after two passages. If needed, primary myoblasts were differentiated using a differentiation medium composed of DMEM (Gibco) with 2% Horse Serum (Gibco), 1% Pen/Strep (Gibco). Cells were treated with 50ng/mL of recombinant WNT3A and/or WNT3A proteins (R&D Systems) for a minimum of 24h, or with the RAC1 inhibitor eHop-016 (Sigma) at 1,5"M during 8h. Primary myoblasts overexpressing full-length Pax7 (cloned into the pBrit plasmid vector) were generated by retroviral infection and cultured as previously described (McKinnell et al., 2008) .
Chromatin immunoprecipitation
Primary myoblasts were cross-linked using 1% formaldehyde in PBS 1X for 10 minutes. Glycine was then added to a final concentration of 0,125M for 5 minutes, followed by centrifugation. Cell pellet was washed in PBS 1X, and resuspended in ChIP lysis buffer (50mM Tris-HCl pH 8.0, 10mM EDTA, 0,5% SDS). Chromatin was fragmented using Covaris sonicator. Before ChIP, equal volume of ChIP assay buffer (20mM Tris-HCl pH 8.0, 1,2mM EDTA, 1,1% Triton X-100, 200mM NaCl) was added to adapt the concentration of salts and detergents. Immunoprecipitation was performed using 1mg of chromatin and 30 "l of anti-Flag M2 affinity gel (Sigma) for 3h at 4 °C. Antibody-protein-DNA complexes were collected, washed and eluted, and cross links were reversed according to manufacturer's instructions. DNA was purified by phenol/chloroform purification using linear acrylamide (Ambion) and GlycoBlue (Ambion) as carriers. ChIP enrichment was analyzed by quantitative PCR using Mx3000P (Stratagene).
Immunostaining and EdU incorporation on primary myoblasts
Primary myoblasts were stained for 8min with 4% PFA in PBS then incubated with 0,2% Triton in PBS for 20min at room temperature. Cells were incubated with primary antibodies during 1h at room temperature, followed by several PBS washes and a 1h-incubation with the secondary antibodies. Nuclei were stained with Hoechst. Primary antibodies used were R-spondin1 (Sigma), Phospho-Histone H3 (Cell Signaling), Pax7 (Santa Cruz), Myogenin (Santa Cruz), M-cadherin (BD Biosciences), Myosin Heavy Chains (R&D Systems) and MKI67 (Santa Cruz). EdU incorporation on primary myoblasts was performed with Click-iT EdU Imaging Kits from Invitrogen, according to the manufacturer's protocol. Cells were incubated with EdU during 1h at 37°C.
Scratch assay
Cells were treated with 10"g/mL of Mitomycin-C (Sigma) for 8h before scratching the monolayer of cells in a straight line. Plates were washed few times with PBS and primary myoblasts were incubated in growth medium for 24h at 37°C. If needed, WNT7A recombinant proteins (100ng/mL from R&D Systems) were added in the culture medium. Cells were then fixed with 4% PFA -PBS and nuclei were stained with Hoechst. The numbers of nuclei in the scar were counted manually.
RNA interference
Primary cells were seeded in collagen-coated plate in growth medium without Pen/Strep. SiRNA transfection was performed using Lipofectamin 2000 and OptiMEM according to the manufacturer's protocol. Both siFzd7 and siControl (Ambion) were used at a 50"M concentration.
Live imaging
Cell imaging was performed on a microscope (Zeiss Axio Observer.Z1) with x10 objective under 5% CO 2 at 37°C in differentiation media. Image acquisition was performed with Metamorph software (Molecular Devices) with time points acquired every 8min during 24h. Velocity was calculated with ImageJ software. The minimum velocity is defined as the lowest velocity obtained by cells during the tracking period.
Quantitative real-time PCR (qPCR)
RNA was isolated either by RNeasy Mini Plus Kit (Qiagen) or by TRIzol Reagent followed by a DNAse treatment (Life Technologies). The reverse transcription was performed with 100ng of RNA using the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems). Transcript levels were determined by LightCycler 480 Real-Time PCR System from Roche, using SYBR green I Master from the same company. The melting curves were checked for each experiment and the primers efficiency was calculated by serial sample dilution. Targeted gene expressions were normalized by Cyclophilin reference gene. Sequences of primers used are given in supplementary materials.
Microarray and bioinformatics
The RNA from primary myoblasts were isolated using TRIzol Reagent from Life Technologies according to the manufacturer's protocol. The purity and the quality of the RNA were performed by Bioanalyzer 2100, using Agilent RNA6000 nano chip kit (Agilent Technologies) at the Cochin Institute Genomic facility. RNA were reverse transcribed using the Ovation PicoSL WTA System (Nugen). The product cDNA were then hybridized to GeneChip Mouse Gene 2.1 ST (Affymetrix). The Affymetrix data were normalized using R software (R Development Core Team, 2011) and gene expression levels were compared using one-way ANOVA. In R-spondin1 deficiency myocytes, the genes were selected with p<0,05 significance. The functional analysis of the gene expression levels was interrogated with Ingenuity pathway (Ingenuity Systems, http://www.ingenuity.com).
Western blot analysis
The nuclear and cytoplasmic protein fractions were obtained with NE-PER Nuclear and Cytoplasmic Extraction reagents kit (Thermo Scientific) according to the manufacturer's protocol. Protein amounts were quantified by BCA Protein Assay Kit (Pearce). In each condition, 30"g of proteins was prepared with home-made Laemmli. Samples were runned on NuPAGE 4-12% BIS-TRIS gels (Life Technologies) and transferred on nitrocellulose membranes. After blocking in 5% milk and 0.1% Tween-20 in TBS, membranes were incubated with primary antibodies overnight at 4°C. Secondary antibodies were then incubated on the membrane for 1h at room temperature. Signals were detected using SuperSignalWest Pico Chemiluminescent Substrate 
Statistical analysis
Analysis were performed using 3 to 5 mice and 3 to 6 biological replicates for cell experiments.
Statistical analysis were done using GraphPad software (Prism, CA, USA) with unpaired twotailed Student's t test, the one-way ANOVA or the two-way ANOVA. P< 0.05 was considered statistically significant. Data were expressed as mean±SD. 
Supplemental material
Fig. S1 details skeletal muscle tissue in Rspo1 mutant mice. Fig. S2 shows that Rspo1-null primary myoblast can proliferate efficiently. Fig. S3 presents the increase in muscle cell fusion following Wnt7a stimulation. Table S1 contains the PCR primers sequences.
Accession codes.
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE84016. 
